Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Study ID: NCT05652686
Start Date: 2023-09-05
End Date: 2028-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

203

Intervention / Treatment

Peluntamig (PT217)

Carboplatin + Etoposide

Paclitaxel.

Atezolizumab

Sponsor

Phanes Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy

Study ID: NCT05337631
Start Date: 2021-06-01
End Date: 2026-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1500

Intervention / Treatment
Sponsor

University Hospital Freiburg

Source: clinicaltrials.gov

Share:
Add to list

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Study ID: NCT04375631
Start Date: 2020-12-03
End Date: 2027-03-17
Study Type

Interventional

Study Phase

Phase1

No. of Participants

120

Intervention / Treatment

Cladribine

Cyclophosphamide

Cyclosporine

Cytarabine

Filgrastim

Hematopoietic Cell Transplantation

Mitoxantrone

Mycophenolate Mofetil

Mycophenolate Sodium

Total-Body Irradiation

Again

Fludarabine

Cytarabine

Multigated Acquisition Scan

Echocardiography

X-Ray Imaging

Bone Marrow Biopsy

Bone Marrow Aspiration

Biospecimen Collection

Sponsor

Fred Hutchinson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

Study ID: NCT01530373
Start Date: 2012-02
End Date: 2027-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

110

Intervention / Treatment

Solifenac

Clonidine

Sponsor

University of Arkansas

Source: clinicaltrials.gov

Share:
Add to list

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

Study ID: NCT06529731
Start Date: 2024-09-23
End Date: 2027-10-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

Interferon gamma-1b

Donor Leukocyte Infusion (DLI)

Sponsor

This is it, MD

Source: clinicaltrials.gov

Share:
Add to list

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

Study ID: NCT05856773
Start Date: 2024-03-21
End Date: 2041-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

276

Intervention / Treatment

Proton Therapy

Sponsor

Proton Collaborative Group

Source: clinicaltrials.gov

Share:
Add to list

Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies

Study ID: NCT04311073
Start Date: 2020-06-20
End Date: 2024-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

50

Intervention / Treatment

Tranexamic Acid

Placebos

Sponsor

Eastern Virginia Medical School

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Study ID: NCT04573231
Start Date: 2021-05-24
End Date: 2025-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

13

Intervention / Treatment

18F-DCFPyL

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

Study ID: NCT04175431
Start Date: 2020-09-30
End Date: 2031-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Positron Emission Tomography

Lymphadenectomy

Radiation Therapy

Abiraterone Acetate

Prednisone

Computed Tomography

Abiraterone

PSMA PET Scan

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Engaging Diverse and Underserved Communities in Cancer Awareness Training and Education

Study ID: NCT05761782
Start Date: 2023-03-07
End Date: 2025-03-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1500

Intervention / Treatment

Education

Sponsor

University of California, Davis

Source: clinicaltrials.gov

Share:
Add to list